🇺🇸 FDA
Patent

US 10865200

Nitrogen-containing heterocyclic compound

granted A61KA61K31/045A61K31/13

Quick answer

US patent 10865200 (Nitrogen-containing heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/045, A61K31/13, A61K31/325, A61K31/4035